<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:department>Unknown</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C911D332-78ED-46E2-AB59-3E663AF502B3"><gtr:id>C911D332-78ED-46E2-AB59-3E663AF502B3</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Farmer</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0100873"><gtr:id>AA312629-8F08-4771-A08E-726B72EC9718</gtr:id><gtr:title>Molecular biomarkers of dose and effect of genotoxins</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0100873</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-10-14</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-04-15</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3082170</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>326000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Project Grant</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>270FE1D0-A81D-4953-8D30-6452372820CE</gtr:id><gtr:outcomeId>A0053112E450</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>67000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>7th Framework Programme Coordination Action</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>0A77A61D-9756-4744-9336-6E51F516698B</gtr:id><gtr:outcomeId>djCchgv2dnC0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>226000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>STREP nanotechnologies and nanosciences</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>9D880E08-488D-44CC-BC28-7D435C246726</gtr:id><gtr:outcomeId>634A3A07D590</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>148522</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>International research grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>World Cancer Research Fund</gtr:fundingOrg><gtr:id>397C19B3-6158-42E0-949C-68716368F99A</gtr:id><gtr:outcomeId>66A4B21A8FF0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>216000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Integrated project 6th Framework Programme, Priority 5: Food Quality and Safety</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>106B5815-E433-4C22-9605-C72797F52F30</gtr:id><gtr:outcomeId>7C5818EA2030</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (member)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>079BD6D0-CB8C-4C46-895D-F69B336C29DE</gtr:id><gtr:impact>Advice on carcinogenic risks</gtr:impact><gtr:outcomeId>EB90FF1D06F</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment (Chairman)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>52EC5F21-B94F-4892-B2E5-D671E091912D</gtr:id><gtr:impact>Advice on mutagenic risks</gtr:impact><gtr:outcomeId>632271A03AD</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Committee on Human Biomonitoring for Environmental Toxicants, National Research Council, Washington, USA</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>F132B364-2EDD-4BE7-B47C-01A44148D944</gtr:id><gtr:impact>Advice on human biomonitoring for carcinogens</gtr:impact><gtr:outcomeId>90C4765F26A</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of EFSA Scientific Panel on Contaminants in the Food Chain</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>83D29CA0-4E8B-488E-907C-CB76E9FEFCA6</gtr:id><gtr:outcomeId>aYXucUkXwZo</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>To determine DNA damage and consequent carcinogenic risk caused by environmental carcinogens</gtr:description><gtr:id>60CAC9A9-E48C-499D-98B2-EA56E096915E</gtr:id><gtr:impact>The new biomarkers that we developed improved the sensitivity and selectivity of detection of adducts and oxidative DNA damage as biomarkers of carcinogen exposure, and are suitable for use in human populations exposed to genotoxic compounds from the environment, occupation, food and medical treatment.</gtr:impact><gtr:outcomeId>0587FF1F20B</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mass spectral assays and immunochemical approaches for protein and DNA adducts</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>23041F52-98D3-4AAC-A369-CF7B170204DF</gtr:id><gtr:title>Development of a liquid chromatography-electrospray ionization tandem mass spectrometry method for detecting oxaliplatin-DNA intrastrand cross-links in biological samples.</gtr:title><gtr:parentPublicationTitle>Chemical research in toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39b6e74e29eca2e77b5f2779cc62b87e"><gtr:id>39b6e74e29eca2e77b5f2779cc62b87e</gtr:id><gtr:otherNames>Le Pla RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0893-228X</gtr:issn><gtr:outcomeId>F8EB0A7D5B3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AA37A81-8ABC-4E91-87C2-F799237D2CB1</gtr:id><gtr:title>Evaluation of the DNA damaging potential of cannabis cigarette smoke by the determination of acetaldehyde derived N2-ethyl-2'-deoxyguanosine adducts.</gtr:title><gtr:parentPublicationTitle>Chemical research in toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddd38ca11db008642251078e0d028a02"><gtr:id>ddd38ca11db008642251078e0d028a02</gtr:id><gtr:otherNames>Singh R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0893-228X</gtr:issn><gtr:outcomeId>tPjPFoE6NoR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB99DE6B-3F2C-4C00-9E9F-A29C01E4E791</gtr:id><gtr:title>A novel 14C-postlabeling assay using accelerator mass spectrometry for the detection of O6-methyldeoxy-guanosine adducts.</gtr:title><gtr:parentPublicationTitle>Rapid communications in mass spectrometry : RCM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f701d36e86a7baa37be74716949fc687"><gtr:id>f701d36e86a7baa37be74716949fc687</gtr:id><gtr:otherNames>Tompkins EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0951-4198</gtr:issn><gtr:outcomeId>5420C05B4BA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BAAD047-0CF2-4BD5-9657-1423AE0B55BD</gtr:id><gtr:title>Detection of phosphodiester adducts formed by the reaction of benzo[a]pyrene diol epoxide with 2'-deoxynucleotides using collision-induced dissociation electrospray ionization tandem mass spectrometry.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d1dac985c77b7ec6bdfde4de0853b92"><gtr:id>6d1dac985c77b7ec6bdfde4de0853b92</gtr:id><gtr:otherNames>Gaskell M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>9E5CD4C0942</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB543E8C-A244-429B-A653-96B01F6FEAF2</gtr:id><gtr:title>Toward consensus in the analysis of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine as a noninvasive biomarker of oxidative stress.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53a61ea9ed0e586d5409fbef780250fb"><gtr:id>53a61ea9ed0e586d5409fbef780250fb</gtr:id><gtr:otherNames>European Standards Committee on Urinary (DNA) Lesion Analysis</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>pm_13850_10_19966135</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>081719C3-7D60-4603-BFBC-7B9A60146CB2</gtr:id><gtr:title>Is tamoxifen a genotoxic carcinogen in women?</gtr:title><gtr:parentPublicationTitle>Mutagenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9bfb181c1926dd7c072e90ee249126c"><gtr:id>f9bfb181c1926dd7c072e90ee249126c</gtr:id><gtr:otherNames>Brown K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0267-8357</gtr:issn><gtr:outcomeId>pm_13850_10_19505894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>987D0D38-726A-41A8-AF28-113A142B4973</gtr:id><gtr:title>Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: the increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens.</gtr:title><gtr:parentPublicationTitle>Mutation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba2175013d128932a48276a3b79fd296"><gtr:id>ba2175013d128932a48276a3b79fd296</gtr:id><gtr:otherNames>Farmer PB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-5107</gtr:issn><gtr:outcomeId>DF24613A5BA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E64EA19A-DB50-46EA-888E-446D43BA492B</gtr:id><gtr:title>Correlation of haemoglobin-acrylamide adducts with airborne exposure: an occupational survey.</gtr:title><gtr:parentPublicationTitle>Toxicology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9802b6cfad2a3d63ba3a16dcf9e31f5b"><gtr:id>9802b6cfad2a3d63ba3a16dcf9e31f5b</gtr:id><gtr:otherNames>Jones K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0378-4274</gtr:issn><gtr:outcomeId>0830746B35D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F014826-6919-4CFC-BA12-7B3130A94D22</gtr:id><gtr:title>Quantification of 3-nitrobenzanthrone-DNA adducts using online column-switching HPLC-electrospray tandem mass spectrometry.</gtr:title><gtr:parentPublicationTitle>Chemical research in toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9faa2cf51e37e741e6e8515fe5b10f8a"><gtr:id>9faa2cf51e37e741e6e8515fe5b10f8a</gtr:id><gtr:otherNames>Gamboa da Costa G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0893-228X</gtr:issn><gtr:outcomeId>MooFJ8f6hoa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DD2BE37-D0EE-44E7-BDB5-7507EEF8D827</gtr:id><gtr:title>Evidence that oxidative stress is a risk factor for the development of squamous cell carcinoma in renal transplant patients.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d45110c160c8524137ea325fa28aede"><gtr:id>5d45110c160c8524137ea325fa28aede</gtr:id><gtr:otherNames>Cooke MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>5483E3B2034</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>458E75A9-C179-4E21-B8A4-93BA82984E25</gtr:id><gtr:title>Improving the diagnostic accuracy of N-terminal B-type natriuretic peptide in human systolic heart failure by plasma profiling using mass spectrometry.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33d025d1d4487fb1fdddae693277b7d9"><gtr:id>33d025d1d4487fb1fdddae693277b7d9</gtr:id><gtr:otherNames>Jones DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>67BE46A3906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4A0699B-74F1-48F6-8E08-B66698EEDF41</gtr:id><gtr:title>Evaluation of enzyme-linked immunosorbent assay and liquid chromatography-tandem mass spectrometry methodology for the analysis of 8-oxo-7,8-dihydro-2'-deoxyguanosine in saliva and urine.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d45110c160c8524137ea325fa28aede"><gtr:id>5d45110c160c8524137ea325fa28aede</gtr:id><gtr:otherNames>Cooke MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>6FAFB48E36A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59DA6D2A-AE69-461F-887E-89BF6B4BF8EF</gtr:id><gtr:title>Determination of 5-methyl-2'-deoxycytidine in genomic DNA using high performance liquid chromatography-ultraviolet detection.</gtr:title><gtr:parentPublicationTitle>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d404c9d013ccc6612b52221852b3a70"><gtr:id>2d404c9d013ccc6612b52221852b3a70</gtr:id><gtr:otherNames>Sandhu J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1570-0232</gtr:issn><gtr:outcomeId>AFaHi2KPSQo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5052DD98-80D0-4AA3-A077-245DE321F038</gtr:id><gtr:title>Detection and quantitation of benzo[a]pyrene-derived DNA adducts in mouse liver by liquid chromatography-tandem mass spectrometry: comparison with 32P-postlabeling.</gtr:title><gtr:parentPublicationTitle>Chemical research in toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddd38ca11db008642251078e0d028a02"><gtr:id>ddd38ca11db008642251078e0d028a02</gtr:id><gtr:otherNames>Singh R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0893-228X</gtr:issn><gtr:outcomeId>4B6B2C6DEAC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B6959A2-11BB-4D7C-9107-E6B4967B50AA</gtr:id><gtr:title>Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolism.</gtr:title><gtr:parentPublicationTitle>The Prostate</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/478c4c020c27a188fdecfa06eb531727"><gtr:id>478c4c020c27a188fdecfa06eb531727</gtr:id><gtr:otherNames>Teichert F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0270-4137</gtr:issn><gtr:outcomeId>ns3tafz1E6J</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA8B7767-2B2B-4E1D-AC3C-311EB89A5EA9</gtr:id><gtr:title>Role of GSTT1 deletion in DNA oxidative damage by exposure to polycyclic aromatic hydrocarbons in humans.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/daec8bb18490714c87976aa2c2d95408"><gtr:id>daec8bb18490714c87976aa2c2d95408</gtr:id><gtr:otherNames>Garte S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>CD2B27F6F19</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9860514E-AE1B-40AC-9240-9CC4A836F0B6</gtr:id><gtr:title>Development of a novel site-specific mutagenesis assay using MALDI-ToF MS (SSMA-MS).</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e92b74a0a6b0a902a73841b116ab330"><gtr:id>4e92b74a0a6b0a902a73841b116ab330</gtr:id><gtr:otherNames>McLuckie KI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>A40247B4366</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33CD3CD9-F32C-4B89-B669-E67552FA5D40</gtr:id><gtr:title>DNA adducts: mass spectrometry methods and future prospects.</gtr:title><gtr:parentPublicationTitle>Toxicology and applied pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba2175013d128932a48276a3b79fd296"><gtr:id>ba2175013d128932a48276a3b79fd296</gtr:id><gtr:otherNames>Farmer PB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0041-008X</gtr:issn><gtr:outcomeId>pm_13850_10_15990134</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8E4D911-FAEB-4AC8-8247-A12431CC297D</gtr:id><gtr:title>Mutagenicity of tamoxifen DNA adducts in human endometrial cells and in silico prediction of p53 mutation hotspots.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b2d6cf5fa2f5ec5231859c87c06c845"><gtr:id>2b2d6cf5fa2f5ec5231859c87c06c845</gtr:id><gtr:otherNames>Liapis E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>F58ED294F17</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB423886-5954-440B-B740-E92F3F29DDA7</gtr:id><gtr:title>Biomarkers for isocyanate exposure: Synthesis of isocyanate DNA adducts.</gtr:title><gtr:parentPublicationTitle>Chemical research in toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18db8fcb35e6173e3fa9e6124f4001b6"><gtr:id>18db8fcb35e6173e3fa9e6124f4001b6</gtr:id><gtr:otherNames>Beyerbach A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0893-228X</gtr:issn><gtr:outcomeId>C40E596FBE2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A40FC8B9-EC96-4751-9AFC-ADF307FC6C33</gtr:id><gtr:title>Dose-response relationships for N7-(2-hydroxyethyl)guanine induced by low-dose [14C]ethylene oxide: evidence for a novel mechanism of endogenous adduct formation.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7dae4ff7c07d9e158bf7e4f27ba9f6a"><gtr:id>e7dae4ff7c07d9e158bf7e4f27ba9f6a</gtr:id><gtr:otherNames>Marsden DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>pm_13850_10_19276345</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEE65752-DB2C-4FDC-A19C-64B8D8DDF106</gtr:id><gtr:title>Searching for biomarkers of heart failure in the mass spectra of blood plasma.</gtr:title><gtr:parentPublicationTitle>Proteomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57e7df3b7e460856bfe836141a635b3d"><gtr:id>57e7df3b7e460856bfe836141a635b3d</gtr:id><gtr:otherNames>Willingale R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1615-9853</gtr:issn><gtr:outcomeId>3F47EF67DE6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F409E721-C24B-431D-BE2C-1DA7AF67D737</gtr:id><gtr:title>Effect of vitamin levels on biomarkers of exposure and oxidative damage-the EXPAH study.</gtr:title><gtr:parentPublicationTitle>Mutation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f32bd28f18210fc1f87f46342c867624"><gtr:id>f32bd28f18210fc1f87f46342c867624</gtr:id><gtr:otherNames>Sram RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-5107</gtr:issn><gtr:outcomeId>brdedSneWbX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEC19F78-4A9D-45C1-B57E-37726004E1AC</gtr:id><gtr:title>Determination of endogenous and exogenously derived N7-(2-hydroxyethyl)guanine adducts in ethylene oxide-treated rats.</gtr:title><gtr:parentPublicationTitle>Chemical research in toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7dae4ff7c07d9e158bf7e4f27ba9f6a"><gtr:id>e7dae4ff7c07d9e158bf7e4f27ba9f6a</gtr:id><gtr:otherNames>Marsden DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0893-228X</gtr:issn><gtr:outcomeId>B0943A9B3F7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>973EC3FB-78F5-49F6-9D54-A68D76888229</gtr:id><gtr:title>Simultaneous determination of 8-oxo-2'-deoxyguanosine and 8-oxo-2'-deoxyadenosine in DNA using online column-switching liquid chromatography/tandem mass spectrometry.</gtr:title><gtr:parentPublicationTitle>Rapid communications in mass spectrometry : RCM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddd38ca11db008642251078e0d028a02"><gtr:id>ddd38ca11db008642251078e0d028a02</gtr:id><gtr:otherNames>Singh R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0951-4198</gtr:issn><gtr:outcomeId>46C40831AE4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D61CE9B2-27EA-45F7-9124-0D3F2F906369</gtr:id><gtr:title>Glutathione transferase pi plays a critical role in the development of lung carcinogenesis following exposure to tobacco-related carcinogens and urethane.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3474019781b06f201d69315f29ad00c1"><gtr:id>3474019781b06f201d69315f29ad00c1</gtr:id><gtr:otherNames>Ritchie KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>B2E47A756A9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39C45666-7878-4568-ACEF-5B4871CC5195</gtr:id><gtr:title>Phosphotriester adducts (PTEs): DNA's overlooked lesion.</gtr:title><gtr:parentPublicationTitle>Mutagenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e310cefafae3d1fee60563e9fbbccc15"><gtr:id>e310cefafae3d1fee60563e9fbbccc15</gtr:id><gtr:otherNames>Jones GD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0267-8357</gtr:issn><gtr:outcomeId>TvKYDQ8Vkac</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8636B04-70DB-4A1E-81E5-B261B7A9357D</gtr:id><gtr:title>Tamoxifen forms DNA adducts in human colon after administration of a single [14C]-labeled therapeutic dose.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9bfb181c1926dd7c072e90ee249126c"><gtr:id>f9bfb181c1926dd7c072e90ee249126c</gtr:id><gtr:otherNames>Brown K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>894B6235900</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0FC0816-C925-4E9D-9617-1F6B9BAE2041</gtr:id><gtr:title>Non-invasive assessment of oxidatively damaged DNA: liquid chromatography-tandem mass spectrometry analysis of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e26c327ad00a077602f4661e22c64d6c"><gtr:id>e26c327ad00a077602f4661e22c64d6c</gtr:id><gtr:otherNames>Mistry V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_13850_20_21057935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53B31C5C-3EA4-46A4-BC2D-32B702B13F44</gtr:id><gtr:title>Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice.</gtr:title><gtr:parentPublicationTitle>Carcinogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/038ab8fb85c88b456e5641a6ed288e52"><gtr:id>038ab8fb85c88b456e5641a6ed288e52</gtr:id><gtr:otherNames>Arlt VM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0143-3334</gtr:issn><gtr:outcomeId>45206D1F246</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DF9268B-EF0B-4403-BCAC-AB5FFA86D323</gtr:id><gtr:title>Styrene-oxide N-terminal valine haemoglobin adducts as biomarkers of occupational exposure to styrene.</gtr:title><gtr:parentPublicationTitle>International journal of hygiene and environmental health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/379a5b5d6dd13e3890eeaedc0bb8ec96"><gtr:id>379a5b5d6dd13e3890eeaedc0bb8ec96</gtr:id><gtr:otherNames>Teixeira JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1438-4639</gtr:issn><gtr:outcomeId>451EB621E36</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>002FBBC9-A557-4B00-9365-F4FCBB3792E5</gtr:id><gtr:title>Creating context for the use of DNA adduct data in cancer risk assessment: II. Overview of methods of identification and quantitation of DNA damage.</gtr:title><gtr:parentPublicationTitle>Critical reviews in toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2560735b059af97f69efe887968101f9"><gtr:id>2560735b059af97f69efe887968101f9</gtr:id><gtr:otherNames>Himmelstein MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1040-8444</gtr:issn><gtr:outcomeId>pm_13850_10_19743945</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5D14A54-CE4D-4A43-8568-DD5F1C1ECBB6</gtr:id><gtr:title>Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.</gtr:title><gtr:parentPublicationTitle>Chemical research in toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1d4c9fdeea57189265e66e8f1952100"><gtr:id>d1d4c9fdeea57189265e66e8f1952100</gtr:id><gtr:otherNames>Harrington CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0893-228X</gtr:issn><gtr:outcomeId>tsu4uGNxoFD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>611F657B-6503-4A6D-BDCF-5C1575E4A86F</gtr:id><gtr:title>Determination of 8-oxo-2'-deoxyguanosine and creatinine in murine and human urine by liquid chromatography/tandem mass spectrometry: application to chemoprevention studies.</gtr:title><gtr:parentPublicationTitle>Rapid communications in mass spectrometry : RCM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/478c4c020c27a188fdecfa06eb531727"><gtr:id>478c4c020c27a188fdecfa06eb531727</gtr:id><gtr:otherNames>Teichert F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0951-4198</gtr:issn><gtr:outcomeId>JG1eHzHYWv4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60EBB4DD-86E7-4284-93EC-5F2F5084B297</gtr:id><gtr:title>Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection.</gtr:title><gtr:parentPublicationTitle>Carcinogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddd38ca11db008642251078e0d028a02"><gtr:id>ddd38ca11db008642251078e0d028a02</gtr:id><gtr:otherNames>Singh R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0143-3334</gtr:issn><gtr:outcomeId>958AF70E65A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0ADAE12-7D95-49AD-B4BC-68963BDB6579</gtr:id><gtr:title>Phosphate alkylation in different DNA substrates: the role of local DNA sequence and electrophile character in determining the nonrandom nature of phosphotriester adduct formation.</gtr:title><gtr:parentPublicationTitle>Chemical research in toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39b6e74e29eca2e77b5f2779cc62b87e"><gtr:id>39b6e74e29eca2e77b5f2779cc62b87e</gtr:id><gtr:otherNames>Le Pla RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0893-228X</gtr:issn><gtr:outcomeId>CAA15B40B54</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A834EFC-0EB9-4885-915C-64F7AD81962F</gtr:id><gtr:title>Styrene-oxide N-terminal valine haemoglobin adducts in reinforced plastic workers: possible influence of genetic polymorphism of drug-metabolising enzymes.</gtr:title><gtr:parentPublicationTitle>Toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/379a5b5d6dd13e3890eeaedc0bb8ec96"><gtr:id>379a5b5d6dd13e3890eeaedc0bb8ec96</gtr:id><gtr:otherNames>Teixeira JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0300-483X</gtr:issn><gtr:outcomeId>D5156AE9C67</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F882B75F-7BD7-4103-8EC0-07419D1C9A9B</gtr:id><gtr:title>Analysis of urinary 8-oxo-7,8-dihydro-purine-2'-deoxyribonucleosides by LC-MS/MS and improved ELISA.</gtr:title><gtr:parentPublicationTitle>Free radical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b207124a9450e09247580bdb48b3d6dd"><gtr:id>b207124a9450e09247580bdb48b3d6dd</gtr:id><gtr:otherNames>Evans MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1029-2470</gtr:issn><gtr:outcomeId>gkjvtTtfHuC</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0100873</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>